ATRC vs IONS · rev $294.9M vs rev $514.0M
AtriCure Inc (ATRC) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
AtriCure Inc (ATRC) is a medical instruments & supplies company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported ATRC revenue for 2026-06-30 was $294.9M. Net income was $9.1M. ATRC currently screens at market cap $1.37B.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
ATRC currently screens at market cap $1.37B. IONS currently screens at market cap $12.28B.
Not investment advice. Open the ATRC and IONS stock pages for the full models.
Not investment advice.